ASPH-1047

N/A

Report date: 2025/01/26 15:05:56
NME

Base Information

Drug NameASPH-1047
Drug Alias Namenext generation TGF-beta inhibitors (Isarna Therapeutics)next generation TGF-beta inhibitors (Antisense)ASPH-1047
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionTransforming growth factor beta receptor 1 inhibitors
TargetsTransforming growth factor beta receptor 1
Therapy Area/IndicationsFibrosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIsarna Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesIsarna Therapeutics Gmbh
Inactive CompaniesN/A
Active IndicationsFibrosisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A